MannKind Submits NDA for Afresa for Treatment of Diabetes
...Corporation today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) requesting approval of Afresa (insulin monomer human [rDNA origin]) Inhalation Powder and the Afresa Inhaler for the treatment of adults with type 1 or type 2 diabetes mellitus...
New Drug Applications (FDA) · More like this

Emisphere Technologies Receives Milestone Payment from MannKind Corporation
...in connection with MannKind's recent filing and the U.S. Food & Drug Administration's (FDA's) acceptance of MannKind's New Drug Application for Afresa, an ultra rapid-acting insulin. In February 2008, Emisphere sold to MannKind certain Emisphere patents and a patent application relating to diketopiperazine...
New Drug Applications (FDA) · More like this

Having trouble finding what you want?

• Try browsing our A-Z List of Drug Names or our Medical Encyclopedia.
• Try posting your query on the Drugs.com Community Discussion Boards
• Drug Interactions Checker provides detailed information on drug-drug and drug-food interactions.
• Pill Identifier will help you identify an unknown pill by imprint code or shape/color.
• Image Search is helpful if you want to know what a certain pill looks like.
• News, FDA Approvals or In The Pipeline may help if the drug you are looking for is a new drug.